Sumarago, Bb Boy .
HRN: 21-39-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/22/2022
06/29/2022
IV
27mg
Q8
RDS/ Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes